CA3188292A1 - Novel cycloalkenone compound or salt thereof - Google Patents
Novel cycloalkenone compound or salt thereofInfo
- Publication number
- CA3188292A1 CA3188292A1 CA3188292A CA3188292A CA3188292A1 CA 3188292 A1 CA3188292 A1 CA 3188292A1 CA 3188292 A CA3188292 A CA 3188292A CA 3188292 A CA3188292 A CA 3188292A CA 3188292 A1 CA3188292 A1 CA 3188292A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- compound
- added
- methyl group
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020135328 | 2020-08-07 | ||
| JP2020-135328 | 2020-08-07 | ||
| PCT/JP2021/029246 WO2022030606A1 (ja) | 2020-08-07 | 2021-08-06 | 新規なシクロアルケノン化合物又はその塩 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3188292A1 true CA3188292A1 (en) | 2022-02-10 |
Family
ID=80118163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3188292A Pending CA3188292A1 (en) | 2020-08-07 | 2021-08-06 | Novel cycloalkenone compound or salt thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230295068A1 (https=) |
| EP (1) | EP4194435A4 (https=) |
| JP (1) | JP7109705B2 (https=) |
| KR (1) | KR20230043923A (https=) |
| CN (1) | CN116096361B (https=) |
| AU (1) | AU2021321705B2 (https=) |
| BR (1) | BR112023001832A2 (https=) |
| CA (1) | CA3188292A1 (https=) |
| MX (1) | MX2023001536A (https=) |
| TW (1) | TWI829001B (https=) |
| WO (1) | WO2022030606A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4477642A4 (en) * | 2022-02-09 | 2026-02-25 | Taiho Pharmaceutical Co Ltd | CRYSTALLINE FORM OF CYCLOHEXENONE COMPOUND |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6228893B1 (en) * | 1997-08-13 | 2001-05-08 | Meiji Milk Products Co., Ltd. | Cyclohexenone long-chain alcohol and medicament containing same |
| JP3836684B2 (ja) | 2001-02-19 | 2006-10-25 | 明治乳業株式会社 | 排尿障害治療剤 |
| WO2009111576A2 (en) | 2008-03-05 | 2009-09-11 | Edison Pharmaceuticals, Inc. | 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES |
| CA2883879A1 (en) | 2012-09-07 | 2014-03-13 | Edison Pharmaceuticals, Inc. | Quinone derivatives for use in the modulation of redox status of individuals |
| WO2017106803A1 (en) | 2015-12-17 | 2017-06-22 | Bioelectron Technology Corporation | Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
| ES2849425T3 (es) | 2016-01-22 | 2021-08-18 | Taiho Pharmaceutical Co Ltd | Método de fabricación de alcohol de cadena larga de ciclohexenona de alta pureza |
| TWI831738B (zh) * | 2016-12-16 | 2024-02-11 | 美商瑞塔醫藥有限責任公司 | 用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物 |
-
2021
- 2021-08-06 KR KR1020237006213A patent/KR20230043923A/ko active Pending
- 2021-08-06 AU AU2021321705A patent/AU2021321705B2/en active Active
- 2021-08-06 WO PCT/JP2021/029246 patent/WO2022030606A1/ja not_active Ceased
- 2021-08-06 JP JP2022518890A patent/JP7109705B2/ja active Active
- 2021-08-06 US US18/040,862 patent/US20230295068A1/en active Pending
- 2021-08-06 TW TW110129168A patent/TWI829001B/zh active
- 2021-08-06 BR BR112023001832A patent/BR112023001832A2/pt unknown
- 2021-08-06 MX MX2023001536A patent/MX2023001536A/es unknown
- 2021-08-06 CA CA3188292A patent/CA3188292A1/en active Pending
- 2021-08-06 EP EP21853226.5A patent/EP4194435A4/en active Pending
- 2021-08-06 CN CN202180057124.1A patent/CN116096361B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| TW202216650A (zh) | 2022-05-01 |
| US20230295068A1 (en) | 2023-09-21 |
| JP7109705B2 (ja) | 2022-07-29 |
| TWI829001B (zh) | 2024-01-11 |
| MX2023001536A (es) | 2023-03-08 |
| BR112023001832A2 (pt) | 2023-02-23 |
| WO2022030606A1 (ja) | 2022-02-10 |
| KR20230043923A (ko) | 2023-03-31 |
| JPWO2022030606A1 (https=) | 2022-02-10 |
| CN116096361A (zh) | 2023-05-09 |
| EP4194435A1 (en) | 2023-06-14 |
| AU2021321705B2 (en) | 2024-02-29 |
| AU2021321705A1 (en) | 2023-03-09 |
| EP4194435A4 (en) | 2024-09-25 |
| CN116096361B (zh) | 2025-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3650449B1 (en) | Fxr receptor agonist | |
| Song et al. | Base promoted synthesis of novel indole-dithiocarbamate compounds as potential anti-inflammatory therapeutic agents for treatment of acute lung injury | |
| CN104520268B (zh) | Ssao的取代的3‑卤代烯丙基胺抑制剂及其用途 | |
| US11542298B2 (en) | Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof | |
| US20050215534A9 (en) | 3-Nitrogen-6, 7-dioxygen steroids and uses related thereto | |
| CN110128432B (zh) | 含氮三环化合物及其在药物中的应用 | |
| US10105373B2 (en) | Fused triterpene compounds and uses thereof | |
| EP4365170A1 (en) | Amide compound and use thereof | |
| CA3188292A1 (en) | Novel cycloalkenone compound or salt thereof | |
| US8530504B2 (en) | Pyrazolothiazole compound | |
| US12274694B2 (en) | Dizocilpine derivatives as peripheral NMDA receptor antagonists | |
| US20230002366A1 (en) | Indene derivatives useful in treating pain and inflammation | |
| CN121001992A (zh) | 咪唑基与二硝基苯基结合的衍生物及其用途 | |
| CN104250247B (zh) | 新型槐定碱类衍生物槐定酸、槐定醇、槐定酯、槐定醚及其制备方法和用途 | |
| HK40087434A (zh) | 新型环烯酮化合物或其盐 | |
| HK40087434B (zh) | 新型环烯酮化合物或其盐 | |
| CN118684668A (zh) | 螺环类化合物及其药物组合物、制备方法和用途 | |
| WO2025067414A1 (zh) | 吡唑羧酸衍生物及其在医药上的应用 | |
| CN113880747A (zh) | 一种吲哚衍生物及其应用 | |
| BR112020000180B1 (pt) | Compostos agonistas do receptor fxr, formulação farmacêutica que contém os mesmos e uso dos compostos para prevenir e/ou tratar doenças mediadas por fxr | |
| JPH0429678B2 (https=) | ||
| JPH09227563A (ja) | 複素環式化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20230203 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20240820 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20241018 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241213 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241213 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250416 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250416 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260210 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260210 |